AngioScore, Inc. was founded in 2003 with the mission of developing, manufacturing, and marketing leading edge tools for endovascular therapy. Traditional balloon angioplasty catheters have evolved little over the past 15 years and they have numerous limitations. The innovative design of the AngioSculpt Scoring Balloon Catheter addresses these limitations and provides an important new interventional tool to help interventional cardiologists, interventional radiologists, and endovascular surgeons improve clinical outcomes and patient care. The company’s senior management team has built and led successful companies in interventional cardiology, cardiac surgery, and cardiac rhythm management. Our Medical Advisory Board is made up of world class interventional cardiology practitioners and researchers.